Shaun Foy

Co-founder - CRISPR Therapeutics & ERS Genomics

Co-founder of CRISPR Therapeutics (Switzerland) and ERS Genomics (Ireland), two of the leading companies commercialising the CRISPR/Cas9 gene editing technology. A biotech entrepreneur with significant startup experience and a strong investment track record as a former partner of a leading venture capital firm. North American and European footprints with a broad industry network and significant experience in startups, sourcing and selecting opportunities, financing, structuring deals and managing public & private investments. Specialties: Biotech ¦ Start Ups ¦ Venture Capital ¦ Investment Management ¦ Business Development Co-founder of CRISPR Therapeutics (Switzerland) and ERS Genomics (Ireland), two of the leading companies commercialising the CRISPR/Cas9 gene editing technology. A biotech entrepreneur with significant startup experience and a strong investment track record as a former partner of a leading venture capital firm. North American and European footprints with a broad industry network and significant experience in startups, sourcing and selecting opportunities, financing, structuring deals and managing public & private investments. Specialties: Biotech ¦ Start Ups ¦ Venture Capital ¦ Investment Management ¦ Business Development